Global and United States Ophthalmic Drugs Market Insights, Forecast to 2027

Global and United States Ophthalmic Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Ophthalmic Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Ophthalmic Drugs Market Size Growth Rate by Type
1.2.2 Anti-allergy
1.2.3 Anti-VEGF Agents
1.2.4 Anti-inflammatory
1.2.5 Anti-glaucoma
1.3 Market by Application
1.3.1 Global Ophthalmic Drugs Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ophthalmic Drugs Market Size, Estimates and Forecasts
2.1.1 Global Ophthalmic Drugs Revenue 2016-2027
2.1.2 Global Ophthalmic Drugs Sales 2016-2027
2.2 Global Ophthalmic Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Ophthalmic Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Ophthalmic Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Ophthalmic Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Ophthalmic Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Ophthalmic Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Ophthalmic Drugs Revenue Forecast by Region (2022-2027)
3 Global Ophthalmic Drugs Competitor Landscape by Players
3.1 Global Top Ophthalmic Drugs Manufacturers by Sales
3.1.1 Global Ophthalmic Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Ophthalmic Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Ophthalmic Drugs Manufacturers by Revenue
3.2.1 Key Ophthalmic Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Ophthalmic Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Ophthalmic Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Ophthalmic Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Ophthalmic Drugs Revenue in 2020
3.2.6 Global Ophthalmic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Ophthalmic Drugs Price by Manufacturers
3.4 Global Ophthalmic Drugs Manufacturing Base Distribution, Product Types
3.4.1 Ophthalmic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ophthalmic Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Ophthalmic Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Ophthalmic Drugs Market Size by Type (2016-2021)
4.1.1 Global Ophthalmic Drugs Sales by Type (2016-2021)
4.1.2 Global Ophthalmic Drugs Revenue by Type (2016-2021)
4.1.3 Ophthalmic Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Ophthalmic Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Ophthalmic Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Ophthalmic Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Ophthalmic Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Ophthalmic Drugs Market Size by Application (2016-2021)
5.1.1 Global Ophthalmic Drugs Sales by Application (2016-2021)
5.1.2 Global Ophthalmic Drugs Revenue by Application (2016-2021)
5.1.3 Ophthalmic Drugs Price by Application (2016-2021)
5.2 Ophthalmic Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Ophthalmic Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Ophthalmic Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Ophthalmic Drugs Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Ophthalmic Drugs Market Size YoY Growth 2016-2027
6.1.1 United States Ophthalmic Drugs Sales YoY Growth 2016-2027
6.1.2 United States Ophthalmic Drugs Revenue YoY Growth 2016-2027
6.1.3 United States Ophthalmic Drugs Market Share in Global Market 2016-2027
6.2 United States Ophthalmic Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Ophthalmic Drugs Players by Sales (2016-2021)
6.2.2 United States Top Ophthalmic Drugs Players by Revenue (2016-2021)
6.3 United States Ophthalmic Drugs Historic Market Review by Type (2016-2021)
6.3.1 United States Ophthalmic Drugs Sales Market Share by Type (2016-2021)
6.3.2 United States Ophthalmic Drugs Revenue Market Share by Type (2016-2021)
6.3.3 United States Ophthalmic Drugs Price by Type (2016-2021)
6.4 United States Ophthalmic Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Ophthalmic Drugs Sales Forecast by Type (2022-2027)
6.4.2 United States Ophthalmic Drugs Revenue Forecast by Type (2022-2027)
6.4.3 United States Ophthalmic Drugs Price Forecast by Type (2022-2027)
6.5 United States Ophthalmic Drugs Historic Market Review by Application (2016-2021)
6.5.1 United States Ophthalmic Drugs Sales Market Share by Application (2016-2021)
6.5.2 United States Ophthalmic Drugs Revenue Market Share by Application (2016-2021)
6.5.3 United States Ophthalmic Drugs Price by Application (2016-2021)
6.6 United States Ophthalmic Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Ophthalmic Drugs Sales Forecast by Application (2022-2027)
6.6.2 United States Ophthalmic Drugs Revenue Forecast by Application (2022-2027)
6.6.3 United States Ophthalmic Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Ophthalmic Drugs Market Size YoY Growth 2016-2027
7.2 North America Ophthalmic Drugs Market Facts & Figures by Country
7.2.1 North America Ophthalmic Drugs Sales by Country (2016-2021)
7.2.2 North America Ophthalmic Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Ophthalmic Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Ophthalmic Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Ophthalmic Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Ophthalmic Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Ophthalmic Drugs Market Size YoY Growth 2016-2027
9.2 Europe Ophthalmic Drugs Market Facts & Figures by Country
9.2.1 Europe Ophthalmic Drugs Sales by Country (2016-2021)
9.2.2 Europe Ophthalmic Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Ophthalmic Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Ophthalmic Drugs Market Facts & Figures by Country
10.2.1 Latin America Ophthalmic Drugs Sales by Country (2016-2021)
10.2.2 Latin America Ophthalmic Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Ophthalmic Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Ophthalmic Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Ophthalmic Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Ophthalmic Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Santen Pharmaceutical
12.1.1 Santen Pharmaceutical Corporation Information
12.1.2 Santen Pharmaceutical Description and Business Overview
12.1.3 Santen Pharmaceutical Ophthalmic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Santen Pharmaceutical Ophthalmic Drugs Products Offered
12.1.5 Santen Pharmaceutical Recent Development
12.2 Bausch Health
12.2.1 Bausch Health Corporation Information
12.2.2 Bausch Health Description and Business Overview
12.2.3 Bausch Health Ophthalmic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bausch Health Ophthalmic Drugs Products Offered
12.2.5 Bausch Health Recent Development
12.3 Takeda
12.3.1 Takeda Corporation Information
12.3.2 Takeda Description and Business Overview
12.3.3 Takeda Ophthalmic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Takeda Ophthalmic Drugs Products Offered
12.3.5 Takeda Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Ophthalmic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Ophthalmic Drugs Products Offered
12.4.5 Novartis Recent Development
12.5 Genentech
12.5.1 Genentech Corporation Information
12.5.2 Genentech Description and Business Overview
12.5.3 Genentech Ophthalmic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Genentech Ophthalmic Drugs Products Offered
12.5.5 Genentech Recent Development
12.6 Allergan
12.6.1 Allergan Corporation Information
12.6.2 Allergan Description and Business Overview
12.6.3 Allergan Ophthalmic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Allergan Ophthalmic Drugs Products Offered
12.6.5 Allergan Recent Development
12.7 Sun Pharmaceutical Industries
12.7.1 Sun Pharmaceutical Industries Corporation Information
12.7.2 Sun Pharmaceutical Industries Description and Business Overview
12.7.3 Sun Pharmaceutical Industries Ophthalmic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sun Pharmaceutical Industries Ophthalmic Drugs Products Offered
12.7.5 Sun Pharmaceutical Industries Recent Development
12.8 Actavis Generics
12.8.1 Actavis Generics Corporation Information
12.8.2 Actavis Generics Description and Business Overview
12.8.3 Actavis Generics Ophthalmic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Actavis Generics Ophthalmic Drugs Products Offered
12.8.5 Actavis Generics Recent Development
12.9 Regeneron Pharmaceuticals
12.9.1 Regeneron Pharmaceuticals Corporation Information
12.9.2 Regeneron Pharmaceuticals Description and Business Overview
12.9.3 Regeneron Pharmaceuticals Ophthalmic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Regeneron Pharmaceuticals Ophthalmic Drugs Products Offered
12.9.5 Regeneron Pharmaceuticals Recent Development
12.10 Pfizer
12.10.1 Pfizer Corporation Information
12.10.2 Pfizer Description and Business Overview
12.10.3 Pfizer Ophthalmic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Pfizer Ophthalmic Drugs Products Offered
12.10.5 Pfizer Recent Development
12.11 Santen Pharmaceutical
12.11.1 Santen Pharmaceutical Corporation Information
12.11.2 Santen Pharmaceutical Description and Business Overview
12.11.3 Santen Pharmaceutical Ophthalmic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Santen Pharmaceutical Ophthalmic Drugs Products Offered
12.11.5 Santen Pharmaceutical Recent Development
12.12 Bausch and Lomb
12.12.1 Bausch and Lomb Corporation Information
12.12.2 Bausch and Lomb Description and Business Overview
12.12.3 Bausch and Lomb Ophthalmic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Bausch and Lomb Products Offered
12.12.5 Bausch and Lomb Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Ophthalmic Drugs Industry Trends
13.2 Ophthalmic Drugs Market Drivers
13.3 Ophthalmic Drugs Market Challenges
13.4 Ophthalmic Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ophthalmic Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Ophthalmic Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Anti-allergy
Table 3. Major Manufacturers of Anti-VEGF Agents
Table 4. Major Manufacturers of Anti-inflammatory
Table 5. Major Manufacturers of Anti-glaucoma
Table 6. Global Ophthalmic Drugs Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 7. Global Ophthalmic Drugs Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Ophthalmic Drugs Sales by Regions (2016-2021) & (K MT)
Table 9. Global Ophthalmic Drugs Sales Market Share by Regions (2016-2021)
Table 10. Global Ophthalmic Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Ophthalmic Drugs Sales Forecast by Region (2022-2027) & (K MT)
Table 12. Global Ophthalmic Drugs Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Ophthalmic Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Ophthalmic Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Ophthalmic Drugs Sales by Manufacturers (2016-2021) (K MT)
Table 16. Global Ophthalmic Drugs Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Ophthalmic Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 18. Ophthalmic Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Ophthalmic Drugs Revenue Share by Manufacturers (2016-2021)
Table 20. Global Ophthalmic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Ophthalmic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmic Drugs as of 2020)
Table 22. Key Manufacturers Ophthalmic Drugs Price (2016-2021) (USD/MT)
Table 23. Ophthalmic Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Ophthalmic Drugs Product Type
Table 25. Date of International Manufacturers Enter into Ophthalmic Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Ophthalmic Drugs Sales by Type (2016-2021) (K MT)
Table 28. Global Ophthalmic Drugs Sales Share by Type (2016-2021)
Table 29. Global Ophthalmic Drugs Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Ophthalmic Drugs Revenue Share by Type (2016-2021)
Table 31. Ophthalmic Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 32. Global Ophthalmic Drugs Sales Forecast by Type (2022-2027) & (K MT)
Table 33. Global Ophthalmic Drugs Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Ophthalmic Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Ophthalmic Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Ophthalmic Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 37. Global Ophthalmic Drugs Sales by Application (2016-2021) (K MT)
Table 38. Global Ophthalmic Drugs Sales Share by Application (2016-2021)
Table 39. Global Ophthalmic Drugs Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Ophthalmic Drugs Revenue Share by Application (2016-2021)
Table 41. Ophthalmic Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 42. Global Ophthalmic Drugs Sales Forecast by Application (2022-2027) & (K MT)
Table 43. Global Ophthalmic Drugs Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Ophthalmic Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Ophthalmic Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Ophthalmic Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 47. United States Ophthalmic Drugs Sales (K MT) of Key Companies (2016-2021)
Table 48. United States Ophthalmic Drugs Sales Share by Company (2016-2021)
Table 49. United States Ophthalmic Drugs Revenue (US$ Million) by Company (2016-2021)
Table 50. United States Ophthalmic Drugs Revenue Share by Company (2016-2021)
Table 51. United States Ophthalmic Drugs Sales (K MT) by Type (2016-2021)
Table 52. United States Ophthalmic Drugs Sales Share by Type (2016-2021)
Table 53. United States Ophthalmic Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. United States Ophthalmic Drugs Price (USD/MT) by Type (2016-2021)
Table 55. United States Ophthalmic Drugs Sales (K MT) by Type (2022-2027)
Table 56. United States Ophthalmic Drugs Sales Share by Type (2022-2027)
Table 57. United States Ophthalmic Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. United States Ophthalmic Drugs Revenue Share by Type (2022-2027)
Table 59. United States Ophthalmic Drugs Price (USD/MT) by Type (2022-2027)
Table 60. United States Ophthalmic Drugs Sales (K MT) by Application (2016-2021)
Table 61. United States Ophthalmic Drugs Sales Share by Application (2016-2021)
Table 62. United States Ophthalmic Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. United States Ophthalmic Drugs Price (USD/MT) by Application (2016-2021)
Table 64. United States Ophthalmic Drugs Sales (K MT) by Application (2022-2027)
Table 65. United States Ophthalmic Drugs Sales Share by Application (2022-2027)
Table 66. United States Ophthalmic Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. United States Ophthalmic Drugs Revenue Share by Application (2022-2027)
Table 68. United States Ophthalmic Drugs Price (USD/MT) by Application (2022-2027)
Table 69. North America Ophthalmic Drugs Sales by Country (2016-2021) & (K MT)
Table 70. North America Ophthalmic Drugs Sales Market Share by Country (2016-2021)
Table 71. North America Ophthalmic Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Ophthalmic Drugs Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Ophthalmic Drugs Sales by Region (2016-2021) & (K MT)
Table 74. Asia Pacific Ophthalmic Drugs Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Ophthalmic Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Ophthalmic Drugs Revenue Market Share by Region (2016-2021)
Table 77. Europe Ophthalmic Drugs Sales by Country (2016-2021) & (K MT)
Table 78. Europe Ophthalmic Drugs Sales Market Share by Country (2016-2021)
Table 79. Europe Ophthalmic Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Ophthalmic Drugs Revenue Market Share by Country (2016-2021)
Table 81. Latin America Ophthalmic Drugs Sales by Country (2016-2021) & (K MT)
Table 82. Latin America Ophthalmic Drugs Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Ophthalmic Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Ophthalmic Drugs Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Ophthalmic Drugs Sales by Country (2016-2021) & (K MT)
Table 86. Middle East and Africa Ophthalmic Drugs Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Ophthalmic Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Ophthalmic Drugs Revenue Market Share by Country (2016-2021)
Table 89. Santen Pharmaceutical Corporation Information
Table 90. Santen Pharmaceutical Description and Business Overview
Table 91. Santen Pharmaceutical Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 92. Santen Pharmaceutical Ophthalmic Drugs Product
Table 93. Santen Pharmaceutical Recent Development
Table 94. Bausch Health Corporation Information
Table 95. Bausch Health Description and Business Overview
Table 96. Bausch Health Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 97. Bausch Health Product
Table 98. Bausch Health Recent Development
Table 99. Takeda Corporation Information
Table 100. Takeda Description and Business Overview
Table 101. Takeda Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 102. Takeda Product
Table 103. Takeda Recent Development
Table 104. Novartis Corporation Information
Table 105. Novartis Description and Business Overview
Table 106. Novartis Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 107. Novartis Product
Table 108. Novartis Recent Development
Table 109. Genentech Corporation Information
Table 110. Genentech Description and Business Overview
Table 111. Genentech Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 112. Genentech Product
Table 113. Genentech Recent Development
Table 114. Allergan Corporation Information
Table 115. Allergan Description and Business Overview
Table 116. Allergan Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 117. Allergan Product
Table 118. Allergan Recent Development
Table 119. Sun Pharmaceutical Industries Corporation Information
Table 120. Sun Pharmaceutical Industries Description and Business Overview
Table 121. Sun Pharmaceutical Industries Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 122. Sun Pharmaceutical Industries Product
Table 123. Sun Pharmaceutical Industries Recent Development
Table 124. Actavis Generics Corporation Information
Table 125. Actavis Generics Description and Business Overview
Table 126. Actavis Generics Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 127. Actavis Generics Product
Table 128. Actavis Generics Recent Development
Table 129. Regeneron Pharmaceuticals Corporation Information
Table 130. Regeneron Pharmaceuticals Description and Business Overview
Table 131. Regeneron Pharmaceuticals Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 132. Regeneron Pharmaceuticals Product
Table 133. Regeneron Pharmaceuticals Recent Development
Table 134. Pfizer Corporation Information
Table 135. Pfizer Description and Business Overview
Table 136. Pfizer Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 137. Pfizer Product
Table 138. Pfizer Recent Development
Table 139. Johnson and Johnson Corporation Information
Table 140. Johnson and Johnson Description and Business Overview
Table 141. Johnson and Johnson Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 142. Johnson and Johnson Product
Table 143. Johnson and Johnson Recent Development
Table 144. Bausch and Lomb Corporation Information
Table 145. Bausch and Lomb Description and Business Overview
Table 146. Bausch and Lomb Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Bausch and Lomb Product
Table 148. Bausch and Lomb Recent Development
Table 149. Ophthalmic Drugs Market Trends
Table 150. Ophthalmic Drugs Market Drivers
Table 151. Ophthalmic Drugs Market Challenges
Table 152. Ophthalmic Drugs Market Restraints
Table 153. Ophthalmic Drugs Customers List
Table 154. Ophthalmic Drugs Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Ophthalmic Drugs Product Picture
Figure 2. Global Ophthalmic Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Anti-allergy Product Picture
Figure 4. Anti-VEGF Agents Product Picture
Figure 5. Anti-inflammatory Product Picture
Figure 6. Anti-glaucoma Product Picture
Figure 7. Global Ophthalmic Drugs Sales Market Share by Application in 2020 & 2027
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Pharmacy
Figure 11. Ophthalmic Drugs Report Years Considered
Figure 12. Global Ophthalmic Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Ophthalmic Drugs Market Size 2016-2027 (US$ Million)
Figure 14. Global Ophthalmic Drugs Sales 2016-2027 (K MT)
Figure 15. Global Ophthalmic Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Ophthalmic Drugs Sales Market Share by Region (2016-2021)
Figure 17. Global Ophthalmic Drugs Sales Market Share by Region in 2020
Figure 18. Global Ophthalmic Drugs Revenue Market Share by Region (2016-2021)
Figure 19. Global Ophthalmic Drugs Revenue Market Share by Region in 2020
Figure 20. Global Ophthalmic Drugs Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Ophthalmic Drugs Revenue in 2020
Figure 22. Ophthalmic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Ophthalmic Drugs Sales Market Share by Type (2016-2021)
Figure 24. Global Ophthalmic Drugs Sales Market Share by Type in 2020
Figure 25. Global Ophthalmic Drugs Revenue Market Share by Type (2016-2021)
Figure 26. Global Ophthalmic Drugs Revenue Market Share by Type in 2020
Figure 27. Global Ophthalmic Drugs Sales Market Share by Application (2016-2021)
Figure 28. Global Ophthalmic Drugs Sales Market Share by Application in 2020
Figure 29. Global Ophthalmic Drugs Revenue Market Share by Application (2016-2021)
Figure 30. Global Ophthalmic Drugs Revenue Market Share by Application in 2020
Figure 31. United States Ophthalmic Drugs Sales Growth Rate 2016-2027 (K MT)
Figure 32. United States Ophthalmic Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. United States Ophthalmic Drugs Market Share in Global Market 2016-2027
Figure 34. United States 5 and 10 Largest Ophthalmic Drugs Players Market Share by Revenue in Ophthalmic Drugs in 2020
Figure 35. United States Ophthalmic Drugs Revenue Share by Type (2016-2021)
Figure 36. United States Ophthalmic Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 37. United States Ophthalmic Drugs Revenue Share by Application (2016-2021)
Figure 38. United States Ophthalmic Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Ophthalmic Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 40. North America Ophthalmic Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Ophthalmic Drugs Sales Market Share by Country in 2020
Figure 42. North America Ophthalmic Drugs Revenue Market Share by Country in 2020
Figure 43. U.S. Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 44. U.S. Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 46. Canada Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Ophthalmic Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 48. Europe Ophthalmic Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Ophthalmic Drugs Sales Market Share by Country in 2020
Figure 50. Europe Ophthalmic Drugs Revenue Market Share by Country in 2020
Figure 51. Germany Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 52. Germany Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 54. France Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 56. U.K. Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 58. Italy Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 60. Russia Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Ophthalmic Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 62. Asia Pacific Ophthalmic Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Ophthalmic Drugs Sales Market Share by Region in 2020
Figure 64. Asia Pacific Ophthalmic Drugs Revenue Market Share by Region in 2020
Figure 65. China Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 66. China Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 68. Japan Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 70. South Korea Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 72. India Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 74. Australia Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 76. Taiwan Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 78. Indonesia Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 80. Thailand Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 82. Malaysia Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 84. Philippines Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 86. Vietnam Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Ophthalmic Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 88. Latin America Ophthalmic Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Ophthalmic Drugs Sales Market Share by Country in 2020
Figure 90. Latin America Ophthalmic Drugs Revenue Market Share by Country in 2020
Figure 91. Mexico Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 92. Mexico Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 94. Brazil Ophthalmic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Ophthalmic Drugs Sales Growth Rate (2016-2021) (K MT)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Artificial Tears Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91

Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......

Global Contact Lens Solution Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96

Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......

Global Latanoprost Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......

Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......

Global Dry Eye Syndrome Drugs Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82

The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......

Global Eye Drops & Lubricants Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112

According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......

Global Conjunctivitis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98

According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......

Global Contact Lens Solution Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118

According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......

Global Latanoprost Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs